author-photo

Melissa Gallery

Takeda Pharmaceutical Company

3

Papers

7

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Preclinical Antitumor Activity and Biodistribution of a Novel Anti-GCC Antibody-Drug Conjugate in Patient-Derived Xenografts.

2020 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (2)
Abstract B120: TAK-164, a GCC-targeted antibody-drug conjugate (ADC) for the treatment of colorectal cancers and other GI malignancies

2018 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (5)
Abstract 365: Using radionuclear imaging and mechanistic modeling to assess the therapeutic potential of antibody-drug conjugates (ADCs)

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)